Trastuzumab and its Role in Oncology
Trastuzumab, marketed under brand names like Herceptin, is a monoclonal antibody used primarily in the treatment of HER2-positive breast cancer and other HER2-positive cancers. It has significantly improved outcomes for patients by targeting the HER2 protein overexpressed in these cancers, thereby inhibiting tumor growth and reducing the risk of recurrence....
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian